ArticleNeuroradiology2024

Multiparametric MRI-based fusion radiomics for predicting telomerase reverse transcriptase (TERT) promoter mutations and progression-free survival in glioblastoma: a multicentre study.

Hongbo Zhang et al.PubMed ↗Publisher ↗

No numbers read from the abstract.